| scholarly article | Q13442814 |
| P50 | author | Roberto Pola | Q39362021 |
| Sergio Rutella | Q42054583 | ||
| Silvio Danese | Q89573798 | ||
| P2093 | author name string | Miquel Sans | |
| Antonio Gasbarrini | |||
| Carol de la Motte | |||
| Claudio Fiocchi | |||
| Gail West | |||
| Cristina Graziani | |||
| Manijeh H Phillips | |||
| Joe Willis | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| inflammatory bowel diseases | Q917447 | ||
| pathogenesis | Q372016 | ||
| angiogenesis | Q539568 | ||
| P304 | page(s) | 2060-2073 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Angiogenesis as a novel component of inflammatory bowel disease pathogenesis | |
| P478 | volume | 130 |
| Q92235884 | 68Ga-DOTA-E[c(RGDfK)]2 PET Imaging of SHARPIN-Regulated Integrin Activity in Mice |
| Q43168068 | Absence of placental growth factor blocks dextran sodium sulfate-induced colonic mucosal angiogenesis, increases mucosal hypoxia and aggravates acute colonic injury |
| Q46316353 | Active Crohn's disease in the small bowel: evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging |
| Q47102876 | Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases |
| Q34420848 | Adhesion GPCRs are widely expressed throughout the subsections of the gastrointestinal tract |
| Q35211056 | Allyl isothiocyanate ameliorates angiogenesis and inflammation in dextran sulfate sodium-induced acute colitis |
| Q36616466 | An important role of blood and lymphatic vessels in inflammation and allergy |
| Q34997755 | An important role of lymphatic vessel activation in limiting acute inflammation |
| Q38946679 | Angiogenesis and Vascular Endothelial Growth Factor-A Expression Associated with Inflammation in Pediatric Crohn's Disease |
| Q34606176 | Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding |
| Q35953816 | Angiogenesis blockade as a new therapeutic approach to experimental colitis |
| Q26769945 | Angiogenesis in Inflammatory Bowel Disease |
| Q33897226 | Angiopoietin-2 in experimental colitis |
| Q39745485 | Angiopoietin/Tie2 signaling transforms capillaries into venules primed for leukocyte trafficking in airway inflammation |
| Q34765589 | Anti inflammatory and anti angiogenic effect of black raspberry extract on human esophageal and intestinal microvascular endothelial cells |
| Q54365605 | Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cells. |
| Q50689698 | Anti-VEGF therapy reduces intestinal inflammation in Endoglin heterozygous mice subjected to experimental colitis. |
| Q38557650 | Applying nanomedicine in maladaptive inflammation and angiogenesis |
| Q37960387 | Assessment of wall inflammation and fibrosis in Crohn's disease: value of T1-weighted gadolinium-enhanced MR imaging |
| Q42424885 | Bevacizumab and postponed suture leakages after surgery for ulcerative colitis and rectal cancer |
| Q89511222 | Blood and Lymphatic Vasculatures On-Chip Platforms and Their Applications for Organ-Specific In Vitro Modeling |
| Q39046622 | Bowel Thickening in Crohn's Disease: Fibrosis or Inflammation? Diagnostic Ultrasound Imaging Tools. |
| Q34421399 | Bowel perfusion measured with dynamic contrast-enhanced ultrasound predicts treatment outcome in patients with Crohn's disease |
| Q27316086 | Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics |
| Q37776080 | Celiac Disease: Evaluation with Dynamic Contrast-enhanced MR Imaging |
| Q35059363 | Change and significance of IL-8, IL-4, and IL-10 in the pathogenesis of terminal Ileitis in SD rat. |
| Q41911162 | Characterization of biological responses of colorectal cancer cells to anticancer regimens |
| Q33678275 | Chronic inflammation and cytokines in the tumor microenvironment |
| Q26994776 | Clinical use and mechanisms of infliximab treatment on inflammatory bowel disease: a recent update |
| Q90227498 | Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis |
| Q37767725 | Coeliac disease--a diagnostic and therapeutic challenge |
| Q45119053 | Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis. |
| Q55076224 | Comparing the Differential Diagnostic Values of 18F-Alfatide II PET/CT between Tuberculosis and Lung Cancer Patients. |
| Q33905709 | Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis |
| Q40167641 | Critical role of the CD40 CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease |
| Q42759281 | Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease. |
| Q42406987 | Dextran sulfate sodium leads to chronic colitis and pathological angiogenesis in endoglin heterozygous mice |
| Q90303090 | Diffusion and perfusion MRI quantification in ileal Crohn's disease |
| Q37684706 | Dynamic Contrast-Enhanced Magnetic Resonance Enterography and Dynamic Contrast-Enhanced Ultrasonography in Crohn's Disease: An Observational Comparison Study. |
| Q24624985 | Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation |
| Q41221924 | Effect of Niacin on Inflammation and Angiogenesis in a Murine Model of Ulcerative Colitis |
| Q36874416 | Elastic scattering spectroscopy as an optical marker of inflammatory bowel disease activity and subtypes |
| Q33618488 | Endogenous IGF-I and alphaVbeta3 integrin ligands regulate increased smooth muscle hyperplasia in stricturing Crohn's disease |
| Q54273411 | Endoscopic finding of spontaneous hemorrhage correlates with tumor necrosis factor alpha expression in colonic mucosa of patients with ulcerative colitis. |
| Q33467424 | Endoscopy in patients with diarrhea during treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors: Is the cause in the mucosa? |
| Q37580251 | Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature. |
| Q33578550 | Epidermal growth factor receptor signaling modulates chemokine (CXC) ligand 5 expression and is associated with villus angiogenesis after small bowel resection |
| Q47386425 | Estimating the arterial input function from dynamic contrast-enhanced MRI data with compensation for flow enhancement (II): Applications in spine diagnostics and assessment of crohn's disease |
| Q64276589 | Evaluation of duodenal perfusion by contrast-enhanced ultrasonography in dogs with chronic inflammatory enteropathy and intestinal lymphoma |
| Q37847061 | Extraluminal factors contributing to inflammatory bowel disease |
| Q41976143 | FOLH1/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities |
| Q30241069 | From obesity to cancer: a review on proposed mechanisms |
| Q42456788 | Functional characterization of the promoter region of human TNFAIP1 gene |
| Q38134594 | Functional imaging of the bowel |
| Q37990395 | Gallium-labelled peptides for imaging of inflammation |
| Q34579752 | Haemostatic system in inflammatory bowel diseases: new players in gut inflammation. |
| Q34876266 | Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice |
| Q40140230 | Hepatocyte growth factor enhances IL-1beta stimulated IL-8 secretion by Caco-2 epithelial cells |
| Q33550441 | High-resolution magnetic resonance colonography and dynamic contrast-enhanced magnetic resonance imaging in a murine model of colitis |
| Q90230346 | Hyaluronan Accelerates Intestinal Mucosal Healing through Interaction with TSG-6 |
| Q26995631 | Hypoxia and Integrin-Mediated Epithelial Restitution during Mucosal Inflammation |
| Q90364641 | IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption |
| Q43192130 | Id1 expression in endothelial cells of the colon is required for normal response to injury |
| Q93148432 | Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis |
| Q26740545 | Imaging of intestinal fibrosis: current challenges and future methods |
| Q35857951 | Immunopathogenesis of IBD: current state of the art. |
| Q37469875 | Increased activation of latent TGF-β1 by αVβ3 in human Crohn's disease and fibrosis in TNBS colitis can be prevented by cilengitide |
| Q40965275 | Increased expression of VEGF and CD31 in postradiation rectal tissue: implications for radiation proctitis |
| Q50622361 | Increased strength of erythrocyte aggregates in blood of patients with inflammatory bowel disease. |
| Q35474247 | Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis |
| Q36986001 | Inflammatory bowel disease: progress and current concepts of etiopathogenesis |
| Q36734939 | Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor |
| Q42726346 | Inhibitor of PI3Kγ ameliorates TNBS-induced colitis in mice by affecting the functional activity of CD4+CD25+FoxP3+ regulatory T cells |
| Q42373419 | Interplay of GTPases and Cytoskeleton in Cellular Barrier Defects during Gut Inflammation. |
| Q91452268 | Interrogating host immunity to predict treatment response in inflammatory bowel disease |
| Q37789692 | Intestinal tissue kallikrein-kinin system in inflammatory bowel disease |
| Q36739682 | Late-breaking news from the "4th International Meeting on Inflammatory Bowel Diseases" Capri, 2006. |
| Q46202324 | Loss of purinergic vascular regulation in the colon during colitis is associated with upregulation of CD39. |
| Q35126452 | Lymphangiogenesis and angiogenesis in abdominal aortic aneurysm |
| Q37553631 | MRI texture analysis (MRTA) of T2-weighted images in Crohn's disease may provide information on histological and MRI disease activity in patients undergoing ileal resection. |
| Q37017694 | MRI texture analysis parameters of contrast-enhanced T1-weighted images of Crohn's disease differ according to the presence or absence of histological markers of hypoxia and angiogenesis |
| Q34391707 | Magnetic resonance enterography in Crohn's disease: Standard and advanced techniques |
| Q92566509 | Magnification endoscopy with optical chromoendoscopy shows strong correlation with histologic inflammation in patients with inflammatory bowel disease |
| Q46803457 | Mannose inhibits hyaluronan synthesis by down-regulation of the cellular pool of UDP-N-acetylhexosamines |
| Q48125931 | Mast Cells Interact with Endothelial Cells to Accelerate In Vitro Angiogenesis |
| Q28080664 | Matrix metalloproteinases in inflammatory bowel disease: an update |
| Q38099727 | Mechanisms of action of anti-tumor necrosis factor α agents in Crohn's disease |
| Q50129416 | Mechanisms of angiogenesis in microbe-regulated inflammatory and neoplastic conditions |
| Q34626040 | Mechanisms of disease: protease functions in intestinal mucosal pathobiology |
| Q33754181 | Mechanisms that mediate the development of fibrosis in patients with Crohn's disease |
| Q34821676 | MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. |
| Q59134251 | Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn's Disease |
| Q37762230 | Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors? |
| Q37155166 | Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades |
| Q57184739 | Mutual Regulation of TLR/NLR and CEACAM1 in the Intestinal Microvasculature: Implications for IBD Pathogenesis and Therapy |
| Q53827365 | Narrow band imaging efficiency in evaluation of mucosal healing/relapse of ulcerative colitis. |
| Q64107595 | Narrow-Band Imaging Colonoscopy to Assess Mucosal Angiogenesis in Ulcerative Colitis |
| Q40674758 | Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study |
| Q37580853 | On the role of ischemia in the pathogenesis of IBD: a review |
| Q35145112 | PAF receptor antagonist Ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer |
| Q53478799 | PET imaging of acute and chronic inflammation in living mice. |
| Q36997603 | PET imaging of inflammation biomarkers |
| Q36027964 | Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner |
| Q36803301 | Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues |
| Q28078361 | Pathophysiological role of guanylate-binding proteins in gastrointestinal diseases |
| Q90745600 | Persistent Enhancement on Contrast-Enhanced Ultrasound Studies of Severe Crohn's Disease: Stuck Bubbles? |
| Q39676371 | Platelet interaction with lymphatics aggravates intestinal inflammation by suppressing lymphangiogenesis. |
| Q41473406 | Poly-γ-glutamic acid attenuates angiogenesis and inflammation in experimental colitis. |
| Q38892276 | Portal hypertensive duodenopathy: clinical, endoscopic, and histopathologic profiles |
| Q28477758 | Preventive and therapeutic euphol treatment attenuates experimental colitis in mice |
| Q36625842 | Pro-angiogenic activity of TLRs and NLRs: a novel link between gut microbiota and intestinal angiogenesis |
| Q36793577 | Promoting inflammatory lymphangiogenesis by vascular endothelial growth factor-C (VEGF-C) aggravated intestinal inflammation in mice with experimental acute colitis |
| Q33799581 | Quantitative analysis of intravenously administered contrast media reveals changes in vascular barrier functions in a murine colitis model. |
| Q45905771 | Quantitative contrast-enhanced ultrasound comparison between inflammatory and fibrotic lesions in patients with Crohn's disease. |
| Q36804314 | Recent advances in basic and clinical aspects of inflammatory bowel disease: which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease? |
| Q42143380 | Repeatability and reproducibility of quantitative contrast-enhanced ultrasonography for assessing duodenal perfusion in healthy dogs. |
| Q57265423 | Restoration of soluble CD146 in patients with Crohnʼs disease treated with the TNF-α antagonist infliximab |
| Q46043731 | Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease. |
| Q45145516 | Role of anti-angiogenic factor endostatin in the pathogenesis of experimental ulcerative colitis |
| Q55313159 | Role of contrast-enhanced ultrasound in evaluation of the bowel. |
| Q37787865 | Role of lymphatic vessels in tumor immunity: passive conduits or active participants? |
| Q34579746 | Role of the endothelium in inflammatory bowel diseases |
| Q37586247 | SPECT-computed tomography in rats with TNBS-induced colitis: A first step toward functional imaging |
| Q37117375 | Shared mechanism of teratogenicity of anti-angiogenic drugs identified in the chicken embryo model. |
| Q36155297 | Signaling of Prostaglandin E Receptors, EP3 and EP4 Facilitates Wound Healing and Lymphangiogenesis with Enhanced Recruitment of M2 Macrophages in Mice |
| Q34161479 | Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation |
| Q37356912 | Substance P, obesity, and gut inflammation |
| Q24656280 | Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitis |
| Q48585326 | Sympathetic vasoconstrictor regulation of mouse colonic submucosal arterioles is altered in experimental colitis |
| Q37482178 | Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis |
| Q34505311 | Temporal colonic gene expression profiling in the recurrent colitis model identifies early and chronic inflammatory processes |
| Q35551204 | Temporal genome expression profile analysis during t-cell-mediated colitis: identification of novel targets and pathways. |
| Q34518038 | Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis |
| Q39276410 | The EGF receptor and HER2 participate in TNF-α-dependent MAPK activation and IL-8 secretion in intestinal epithelial cells |
| Q34526079 | The Role of the Mesentery in Crohn's Disease: The Contributions of Nerves, Vessels, Lymphatics, and Fat to the Pathogenesis and Disease Course |
| Q37421164 | The angiogenic effect of probiotic Bacillus polyfermenticus on human intestinal microvascular endothelial cells is mediated by IL-8. |
| Q36098582 | The cutaneous vascular system in chronic skin inflammation |
| Q41770473 | The neurotensin-HIF-1α-VEGFα axis orchestrates hypoxia, colonic inflammation, and intestinal angiogenesis |
| Q37104149 | The relationship between inflammatory markers, angiogenesis, and obesity |
| Q54775460 | The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease. |
| Q46463601 | The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice. |
| Q37332659 | Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, alpha- and beta-amyrin, in a mouse model of colitis |
| Q41857388 | Thrombospondin and VEGF-R: is there a correlation in inflammatory bowel disease? |
| Q38081198 | Tissue-regenerating functions of coagulation factor XIII. |
| Q35621160 | Unexpected role of anticoagulant protein C in controlling epithelial barrier integrity and intestinal inflammation |
| Q33312378 | Up-regulation of intestinal vascular endothelial growth factor by Afa/Dr diffusely adhering Escherichia coli |
| Q36877837 | Upregulation of vascular endothelial growth factor isoform VEGF-164 and receptors (VEGFR-2, Npn-1, and Npn-2) in rats with cyclophosphamide-induced cystitis |
| Q37359869 | VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164b therapy |
| Q34117538 | VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease |
| Q39649380 | VEGF₁₆₄ differentially regulates neutrophil and T cell adhesion through ItgaL- and ItgaM-dependent mechanisms. |
| Q36702612 | VEGF₁₆₄ isoform specific regulation of T-cell-dependent experimental colitis in mice |
| Q47598080 | Validity of Contrast-enhanced Ultrasonography and Dynamic Contrast-enhanced MR Enterography in the Assessment of Transmural Activity and Fibrosis in Crohn's Disease. |
| Q36758644 | Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine |
| Q39020240 | Vertebrate embryos as tools for anti-angiogenic drug screening and function. |
| Q33422976 | Where are all the Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease? |
| Q92276482 | c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis |
Search more.